Cure My Disease

Don't miss your cure!

 Log in / Sign up

New MRI scan could predict pancreatic cancer treatment success

NCT ID NCT06600906

Recruiting now Diagnosis Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental MRI scan that uses a special contrast agent called hyperpolarized carbon-13 pyruvate to see how pancreatic tumors process nutrients. The goal is to find out if this scan can predict treatment response better than standard MRIs. About 70 adults with advanced pancreatic cancer will be scanned before and after four weeks of standard treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hyperpolarized carbon-13 pyruvate
What this could lead to
If successful, this scan could help doctors quickly tell if a pancreatic cancer treatment is working, allowing them to adjust therapy sooner.
What could go wrong
This is an early study with only 70 participants, so results may not apply to everyone. The scan is experimental and may not prove better than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic ductal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA PANCREATIC DUCTAL ADENOCARCINOMA

Contacts and locations

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.